1 North Wealth Services’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-31
Closed -$3.24K 285
2025
Q4
$3.24K Hold
31
﹤0.01% 230
2025
Q3
$2.87K Hold
31
﹤0.01% 216
2025
Q2
$2.48K Hold
31
﹤0.01% 223
2025
Q1
$2.69K Buy
+31
New +$2.64K ﹤0.01% 219
2019
Q4
$2K Hold
31
﹤0.01% 328
2019
Q3
$2K Buy
+31
New +$1.78K ﹤0.01% 294
2019
Q1
$2K Hold
31
﹤0.01% 275
2018
Q4
$2K Buy
+31
New +$2.09K ﹤0.01% 260

Other funds holding PJP

1 North Wealth Services's PJP Position: Q1 2026 in Review

1 North Wealth Services sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2026, closing a stake of 31 shares — an estimated $3.24K sold.

1 North Wealth Services first reported a position in PJP in Q4 2018 and held it in 8 quarters. The position peaked at $3.24K in Q4 2025. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

  • 1 North Wealth Services reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2026 after selling out during the quarter.
  • 1 North Wealth Services sold 31 Invesco Pharmaceuticals ETF shares in Q1 2026, an estimated $3.24K.
  • 1 North Wealth Services first reported a position in Invesco Pharmaceuticals ETF in Q4 2018 and held it in 8 quarters.
  • 1 North Wealth Services's Invesco Pharmaceuticals ETF position peaked at $3.24K in Q4 2025.
  • 119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on 1 North Wealth Services's 13F filing for Q1 2026, filed 4 May 2026.